Nebenwirkungen · Aldara
ALDARA 5% cream · Abschnitt 4.8 · PDF-Seite 11
HOS-088056 · Präparat HOS-083607
Reports have been received of localised hypopigmentation and hyperpigmentation following imiquimod cream use. Follow-up information suggests that these skin colour changes may be permanent in some patients. In a follow-up of 162 patients five years after treatment for sBCC a mild hypopigmentation was observed in 37% of the patients and a moderate hypopigmentation was observed in 6% of the patients. 56% of the patients have been free of hypopigmentation; hyperpigmentation has not been reported.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-18T11:40:00Z · SHA-256 29a2c6949b9e74d0aba2dc8c33290a7bc20b103110a06b748f4e53afb53b0ce7 · Passage 17ebdc5b8b890d84fec20b2986ceafd2f720a2e2aaa8c31c2b91302fd94052f1 · Zeichen 12239–12737 im Abschnitt